image
Healthcare - Medical - Devices - NASDAQ - US
$ 12.64
1.36 %
$ 556 M
Market Cap
-38.3
P/E
CASH FLOW STATEMENT
-5.72 M OPERATING CASH FLOW
64.42%
19.3 M INVESTING CASH FLOW
701.66%
1.95 M FINANCING CASH FLOW
8.92%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis AxoGen, Inc.
image
Net Income -21.7 M
Depreciation & Amortization 5.55 M
Capital Expenditures -14.9 M
Stock-Based Compensation 14.4 M
Change in Working Capital -10.9 M
Others -3.97 M
Free Cash Flow -20.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Jun-2001 Jun-2000 Jun-1999 Jun-1998 Jun-1997 Jun-1996 Jun-1995 Jun-1994 Jun-1993 Jun-1992 Jun-1991 Jun-1990
OPERATING CASH FLOW
Net Income (21.7) (28.9) (27.0) (23.8) (29.1) (22.4) (10.4) (14.4) (13.4) (17.7) (14.6) (9.4) (9.2) (1.3) 15.0 (1.0) (0.7) (0.4) (0.5) (0.1) (1.3) (2.6) 1.3 (2.9) (1.7) (0.4) (2.3) (0.6) 0.2 0.6 0.7 1.0 0.9 0.4
Depreciation & Amortization 5.6 4.9 4.7 3.5 2.9 0.9 0.6 0.4 0.2 0.2 0.1 0.3 0.3 19.8 K 23 K 23.1 K 22.3 K 25.5 K 20 K 0.2 0.5 0.6 0.5 0.9 0.9 0.8 1.0 1.1 0.9 0.6 0.5 0.3 0.3 0.3
Deferred Income Tax 0 0 3.4 2.2 0 4.4 0.2 0.8 0.1 0.9 68 K 0.4 10.5 (0.6) 48 K 0 0 0 0 0 0 0 0 0.2 0 0 0 100 K 100 K 100 K 0 0 100 K 100 K
Stock Based Compensation 14.4 15.6 10.9 8.5 10.3 7.6 3.6 1.4 1.3 1.0 0.7 0.5 0.3 0.2 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 6.9 2.0 0.8 0.2 2.5 81 K 0.2 2.0 0.6 5.3 4.0 1.3 (9.2) 0 (0.1) 0 0.3 31.6 K 86.8 K 2.0 52.4 K 27.1 K (4.4) 0.7 100 K 100 K 2.3 0 0 100 K 0 0 (0.9) 0.2
Change in Working Capital (10.9) (9.6) (6.3) (0.2) (6.4) (8.4) (3.4) (1.5) (2.0) (0.1) (0.7) (1.8) 0.3 (0.8) 0.5 92.3 K 73.2 K 0.3 (0.3) (1.2) 0.7 1.2 (0.4) (0.2) 0.7 1.0 (0.9) (0.2) (0.9) (1.0) 0.2 (0.2) 0.9 (0.2)
Cash From Operations (5.7) (16.1) (13.4) (9.6) (19.9) (17.9) (9.2) (11.2) (13.1) (10.5) (10.4) (8.7) (7.1) (2.4) 15.4 (0.5) (0.5) 28.8 K (0.7) 0.9 27.3 K (0.8) (2.9) (1.3) (0.2) 1.5 100 K 0.2 100 K 0.3 1.4 1.1 1.3 0.6
INVESTING CASH FLOW
Capital Expenditures (14.9) (21.3) (28.4) (22.6) (121.6) (6.6) (1.3) (1.2) (0.6) (0.6) (0.2) (0.1) 89.5 K 40.7 K 8.68 K 29.9 K 0 0 0 74.6 K 22 K 21.1 K (0.4) (0.4) (0.4) (0.4) (0.2) (0.4) (1.5) (2.1) (0.5) (0.7) (0.6) (0.2)
Other Items 34.2 18.1 4.8 5.6 148.9 (91.6) 0 0 0 0 0 0 7.2 (2.0) 0 0 0 0 60 K 0.9 0.8 81 K 6.5 (0.1) 100 K 0.5 100 K (0.2) 1.3 2.1 (2.1) 100 K 100 K 0.2
Cash From Investing Activities 19.3 (3.2) (23.6) (17.0) 27.3 (98.2) (1.3) (1.2) (0.6) (0.6) (0.2) (0.1) 7.1 (2.0) 8.68 K 29.9 K 0 0 60 K 0.9 0.8 (0.1) 6.2 (0.6) (0.5) 100 K (0.3) (0.6) (0.2) 0 (2.6) (0.6) (0.5) 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (0.2) (0.2) (0.2) 0 0 0 0 (0.4)
Total Debt Repaid 10 K 12 K 15.0 35.0 29 K (22.5) 21 K (3.2) 0 (1.8) 0 15.8 5.8 0 0 0 0 0 2.52 K 12.6 K (0.9) 0.1 0 7 K 0.9 0 0 0 0 0 0 0 0 (0.8)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 (4.3) 0 0 0 0 (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 2.0 1.8 5.5 2.0 4.0 132.4 1.2 1.0 0.3 (0.7) 73.3 K (1.3) (0.4) 2.0 0 0 0 0 83.8 K 17.8 K 0 0 34.7 K 0.9 0 0 100 K 0 (0.2) 100 K 100 K 100 K (1.4) 100 K
Cash From Financing Activities 2.0 1.8 20.5 40.5 4.0 109.8 17.0 16.5 31.3 (0.8) 16.9 14.5 6.4 (4.3) 0 0 18.1 K 0 (0.2) 14 K (0.9) 0.1 34.7 K 0.9 (0.5) 100 K 0 0.3 100 K 0 0 0.5 (0.9) (0.5)
CHANGE IN CASH
Net Change In Cash 15.5 (17.5) (16.6) 13.9 11.4 (6.2) 6.5 4.1 17.7 (11.9) 6.2 5.7 6.4 (8.7) 15.4 (0.5) (0.4) 28.8 K (0.9) 1.8 (0.2) (0.8) 3.3 (0.9) (1.2) 1.5 (0.2) 100 K 0 0.3 (1.2) 1.0 100 K 100 K
FREE CASH FLOW
Free Cash Flow (20.6) (37.3) (41.8) (32.2) (141.5) (24.5) (10.5) (12.4) (13.6) (11.0) (10.7) (8.8) (7.2) (2.5) 15.4 (0.5) (0.5) 28.8 K (0.7) 0.8 49.3 K (0.8) (3.3) (1.7) (0.6) 1.1 100 K (0.2) (1.4) (1.8) 0.9 0.4 0.7 0.4